We are live on
!
Find out more
JAFL
Jay A. Fishman Ltd Portfolio holdings
AUM
$1.12B
1-Year Est. Return
32.75%
This Fund
S&P 500
This Quarter
Est. Return
+14.41%
1 Year Est. Return
+32.75%
3 Year Est. Return
+106.85%
5 Year Est. Return
+144.56%
10 Year Est. Return
+606.28%
AUM
$825M
AUM Growth
+$42.3M
(+5.4%)
Cap. Flow
-$52.2M
Cap. Flow
% of AUM
-6.32%
Top 10 Holdings %
Top 10 Hldgs %
67.92%
Holding
103
New
10
Increased
17
Reduced
46
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$10.8M |
| 2 |
Merck
MRK
|
+$4.9M |
| 3 |
Zoetis
ZTS
|
+$2.56M |
| 4 |
Icahn Enterprises
IEP
|
+$2.35M |
| 5 |
Eli Lilly
LLY
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$16.5M |
| 2 |
AbbVie
ABBV
|
+$13.7M |
| 3 |
JPMorgan Chase
JPM
|
+$6.14M |
| 4 |
Johnson & Johnson
JNJ
|
+$4.88M |
| 5 |
Blackstone
BX
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.33% |
| 2 | Financials | 14.39% |
| 3 | Industrials | 12.41% |
| 4 | Healthcare | 12.15% |
| 5 | Consumer Discretionary | 10.94% |
Similar funds
SL
PTC
CT
C
ACG
CNC
MTCM
EC
Jay A. Fishman Ltd's Q2 2023 Portfolio in Review
As of Q2 2023, Jay A. Fishman Ltd held 103 positions worth $825M, up 5.4% from $783M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Jay A. Fishman Ltd withdrew a net $52.2M in Q2 2023, closing 5 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $1.97M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Industrials.
Against the trend, Jay A. Fishman Ltd opened a new position in Comerica worth $11.4M.
- Jay A. Fishman Ltd's largest Q2 2023 buy was Comerica: 268,325 shares worth $11.4M.
- Jay A. Fishman Ltd added most to Merck in Q2 2023, an estimated $4.9M increase.
- Jay A. Fishman Ltd's biggest Q2 2023 reduction was Apple, cutting an estimated $16.5M.
- Jay A. Fishman Ltd fully exited Bristol-Myers Squibb in Q2 2023, selling an estimated $1.97M.
- Jay A. Fishman Ltd's ten largest holdings make up 68% of its $825M portfolio in Q2 2023.
- Jay A. Fishman Ltd opened 10 new positions and closed 5 in Q2 2023.
- Jay A. Fishman Ltd's portfolio value rose 5.4% quarter-over-quarter to $825M.
Based on Jay A. Fishman Ltd's 13F filing for Q2 2023, filed 15 Aug 2023.